WBI Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,181
Closed -$636K 336
2025
Q4
$636K Sell
5,181
-3,553
-41% -$432K 0.17% 171
2025
Q3
$969K Sell
8,734
-6,203
-42% -$705K 0.25% 115
2025
Q2
$1.66M Sell
14,937
-6,943
-32% -$739K 0.43% 60
2025
Q1
$2.45M Sell
21,880
-7,266
-25% -$750K 0.65% 42
2024
Q4
$2.69M Buy
29,146
+9,731
+50% +$876K 0.67% 39
2024
Q3
$1.63M Buy
19,415
+9,671
+99% +$738K 0.39% 75
2024
Q2
$669K Buy
+9,744
New +$650K 0.16% 105
2023
Q2
Sell
-79,318
Closed -$6.58M 197
2023
Q1
$6.58M Buy
79,318
+60,198
+315% +$4.99M 1.32% 14
2022
Q4
$1.64M Buy
19,120
+570
+3% +$45.1K 0.35% 70
2022
Q3
$1.14M Sell
18,550
-38,054
-67% -$2.4M 0.33% 50
2022
Q2
$3.5M Buy
56,604
+16,383
+41% +$1.01M 0.75% 34
2022
Q1
$2.39M Sell
40,221
-6,201
-13% -$396K 0.39% 68
2021
Q4
$3.25M Buy
46,422
+4,371
+10% +$301K 0.52% 45
2021
Q3
$2.94M Sell
42,051
-75,395
-64% -$5.3M 0.49% 55
2021
Q2
$8.09M Buy
117,446
+42,996
+58% +$2.87M 1.24% 16
2021
Q1
$4.81M Buy
+74,450
New +$4.8M 0.76% 24
2019
Q3
Sell
-188,955
Closed -$12.8M 236
2019
Q2
$12.8M Buy
+188,955
New +$12.4M 1.12% 16
2015
Q3
Sell
-7,540
Closed -$883K 195
2015
Q2
$883K Sell
7,540
-52,307
-87% -$5.72M 0.02% 189
2015
Q1
$5.87M Sell
59,847
-67,717
-53% -$6.88M 0.14% 114
2014
Q4
$12M Buy
+127,564
New +$13.2M 0.33% 62

Other funds holding GILD

WBI Investments's GILD Position: Q1 2026 in Review

WBI Investments sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 5,181 shares — an estimated $636K sold.

WBI Investments first reported a position in GILD in Q4 2014 and held it in 20 quarters. The position peaked at $12.8M in Q2 2019. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • WBI Investments reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • WBI Investments sold 5,181 Gilead Sciences shares in Q1 2026, an estimated $636K.
  • WBI Investments first reported a position in Gilead Sciences in Q4 2014 and held it in 20 quarters.
  • WBI Investments's Gilead Sciences position peaked at $12.8M in Q2 2019.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.